+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Trends in clinical management of women with von Willebrand disease: a survey of 75 women enrolled in haemophilia treatment centres in the United States

Trends in clinical management of women with von Willebrand disease: a survey of 75 women enrolled in haemophilia treatment centres in the United States

Haemophilia 10(2): 158-161

To assess the management of women with von Willebrand disease( vWD) in an Heamophilia Treatment Center (HTC) setting. A total of 75 women with vWd who were registered in HTCs in the United States participated in this study. A telephone interview elicited information about symptoms pertaining to bleeding disorders, diagnostic issues, referral patterns, treatment modalities before and after the enrollment in the HTC, HTC services provided, and satisfaction with care in the HTC. Menorrhagia was the most commonly reported symptom (84%). The average time from the first symptom until clinician recognition was 16 years (range 0-39). In HTC, DDAVP was the most commonly used drug (31%). Of the 75 women, 71 reported a strong positive opinion and satisfaction about their care in the HTCs. Women with VWD were typically diagnosed with the condition well into adulthood, in spite of the fact that majority of them experienced several bleeding symptoms beginning in early childhood. In general an HTC setting is appropriate for management of women with bleeding disorders. Diagnosis, treatment and education provided in the HTCs were viewed positively by those surveyed.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 050852212

Download citation: RISBibTeXText

PMID: 14962204

DOI: 10.1046/j.1351-8216.2003.00832.x

Related references

Management of von Willebrand disease: a survey on current clinical practice from the haemophilia centres of North America. Haemophilia 7(3): 235-241, 2001

Medical, reproductive and psychosocial experiences of women diagnosed with von Willebrand's disease receiving care in haemophilia treatment centres: a case-control study. Haemophilia 9(3): 292-297, 2003

Treatment trends for haemophilia A and haemophilia B in the United States results from the 21 practice patterns survey. 2012

Practice patterns in haemophilia A therapy--a survey of treatment centres in the United States. Haemophilia 9(5): 549-554, 2003

Primary postpartum haemorrhage in women with von Willebrand disease or carriership of haemophilia despite specialised care: a retrospective survey. Haemophilia 21(4): 505-512, 2015

Demographic, clinical, and treatment trends among women diagnosed with vulvar cancer in the United States. Gynecologic Oncology 108(3): 577-583, 2008

Cancers in Patients with von Willebrand Disease: A Survey from the Italian Association of Haemophilia Centres. Seminars in Thrombosis and Hemostasis 42(1): 36-41, 2016

Multidisciplinary management of patients with haemophilia with inhibitors undergoing surgery in the United States: perspectives and best practices derived from experienced treatment centres. Haemophilia 18(6): 971-981, 2012

Treatment of women in the United States with localized, provoked vulvodynia: practice survey of women's health physical therapists. Journal of Reproductive Medicine 52(1): 48-52, 2007

Trends and Disparities in Osteoporosis Screening Among Women in the United States, 2008-2014. American Journal of Medicine 130(3): 306-316, 2016

From the Centers for Disease Control and Prevention. Use of mammography services by women aged > or = 65 years enrolled in Medicare--United States, 1991-93. JAMA 274(18): 1420-1420, 1995

Trends in Ambulatory Management of Urinary Incontinence in Women in the United States. Female Pelvic Medicine and Reconstructive Surgery 23(4): 250-255, 2017

Surveillance of female patients with inherited bleeding disorders in United States Haemophilia Treatment Centres. Haemophilia 17(Suppl. 1): 6, 2011

An inventory of healthy weight practices in federally funded haemophilia treatment centres in the United States. Haemophilia 20(5): 639-643, 2014

Type 3 von Willebrand disease: assessment of complications and approaches to treatment -- results of a patient and Hemophilia Treatment Center Survey in the United States. Haemophilia 10(4): 360-366, 2004